The gabapentin market is capturing a valuation of US$ 2.11 billion in 2023 and is predicted to reach US$ 3.54 billion by 2033. The market is registering a CAGR of 5.3% during the forecast period. How are Manufacturers Developing Suitable Gabapentin Products for Patients? Gabapentin is a medication used to treat seizures, neuropathic pain, and restless leg …
Category Archives: Healthcare Trends
Antimicrobial Wound Care Dressings Market is expected to reach US$ 2.57 billion by 2033 | Says FMI
The global antimicrobial wound care dressings market is expected to be worth US$ 1.38 billion in 2023, with a CAGR of 6.4% from 2023 to 2033. By 2033, the global market is set to reach US$ 2.57 billion. Antimicrobial wound care dressings function as a barrier against germs that may enter the wound and cause infection. The …
Postoperative Nausea and Vomiting (PONV) Management Market value of US$ 3.9 Billion by registering a CAGR of 12.8% in the forecast period 2023 to 2033
During the forecast period 2023 to 2033, Postoperative nausea and vomiting (PONV) management market is expected to grow at a value of 12.8% CAGR, according to Future Market Insights. By the year 2033, the global market for Postoperative nausea and vomiting (PONV) management is expected to rise up to a market valuation of US$ 3.9 Billion. Growth …
Brain Tumor Drugs Market is likely to reach US$ 2.65 billion in 2023 and is expected to be worth US$ 6.30 billion in 2033
From 2023 to 2033, the market for drugs for brain tumors is anticipated to grow at a 9.2% CAGR. Market value is anticipated to reach US$ 2.65 billion in 2023 and US$ 6.30 billion in 2033. The Brain Tumor Drugs Market is likely to grow from US$ 2.65 billion in 2023 to US$ 6.30 billion in 2033. …
Lip Fillers Market is anticipated to progress at a CAGR of 3.8% to reach US$ 1.63 Billion by 2028
Lip Fillers Market is currently valued at around US$ 1.3 Bn, and is anticipated to progress at a CAGR of 3.8% to reach US$ 1.63 Bn by 2028, finds the new market intelligence study by Future Market Insights (FMI). ALLERGAN, Galderma Laboratories, and Merz Pharma GmbH & Co. KGaA retain their lead as the top three …
Medication Management System Market is expected to exhibit a CAGR of 11% from 2022 to 2032 | Exclusive Report by FMI
[300 Pages Report] The global medication management system industry is gaining momentum as lack of enough pharmacists and healthcare professionals is necessitating the requirement for an efficient management system to ensure the workflow. While the pandemic has brought substantial changes in the medical and healthcare industry due to shifted demand-supply patterns, the need to curtail medical errors grew …
United Kingdom in Radiotherapy Devices Market is set to expand at a CAGR of 11.3% from 2022 to 2032
Recent Future Market Insights research titled “Radiotherapy Devices Market” claims that The market for radiation equipment is anticipated to reach US$ 6.4 billion by the end of 2022 and expand at a CAGR of 10.3% from 2022 to 2032. The market is expected to be valued US$17.0 billion by the end of 2032. The equipment …
Diabetic Macular Edema Market are set to witness a CAGR of 1.2% and be valued at around US$ 4.2 Billion by 2032
The global Diabetic Macular Edema Market Size is expected to reach a valuation of US$ 3.7 Billion by the end of 2022, and further expand at a CAGR of 1.2% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 4.2 Billion by the end of 2032. An Uptake of Intravitreal Implants by Patients to Drive Growth of the …
North America in Spinal Cord Stimulators Market is projected to reach US$ 4.1 Billion and register a CAGR of 7.8% from 2022 to 2032
Throughout the projection period, it is expected that the Spinal Cord Stimulators Market would increase in size and reach US$ 5.255 billion. The market for spinal cord stimulators is estimated to grow at a CAGR of more than 7.5% throughout the anticipated time frame. (2022-2032). Between 2022 and 2032, the spinal cord stimulator market is …
Atopic Dermatitis Treatment Market | Sanofi SA, Galderma SA, Allergan Plc. and Novartis | By 2029
The global Atopic Dermatitis Treatment Market was valued US$ 5.2 Billion in 2021 and is expected to reach US$ 7.6 Billion by 2029 is expected to increase at a CAGR of 4.8% during the forecast period of 2022 and 2029. A new market research report by Future Market Insights on the atopic dermatitis treatment market includes global …